S&P 500 gains to extend record run, set for positive week
Cathie Wood’s ARK ETFs have made a series of trades on Wednesday, April 16th, 2025, with a notable increase in Robinhood Markets Inc (NASDAQ:HOOD) shares and a substantial sell-off of UiPath Inc (NYSE:PATH) stock. The daily trade report reveals ARK’s strategy and provides insight into the investment firm’s latest moves.
ARK’s largest dollar-value trade for the day was the purchase of 60,266 shares of Robinhood Markets Inc, amounting to approximately $2,656,525. This move comes after a series of acquisitions of the stock, indicating ARK’s growing interest in the financial services company.
Conversely, ARK sold a total of 234,788 shares of UiPath Inc, valued at around $2,484,057. This sale is part of a continuing trend, as ARK has been reducing its position in the automation software company over the past week.
In addition to these significant trades, ARK also sold 31,817 shares of ARK 21Shares Bitcoin ETF (ARKB) through its ARKW ETF for $120,548, and a minor sale of 88 shares of Prime Medicine Inc (NASDAQ:PRME) was executed for just $116.
The firm’s ARKG ETF parted with 9,610 shares of Repare Therapeutics Inc (NASDAQ:RPTX) at a value of $10,571, continuing a pattern of sales in the biotech company’s stock over recent days.
A new entry into ARK’s portfolio is the 3IQ Solana Staking ETF (SOLQ.U), with a massive purchase of 500,000 shares split evenly between the ARKW and ARKF ETFs. The financial details of this transaction were not disclosed, but the investment marks a significant interest in cryptocurrency-related assets.
Investors following ARK’s trades will note the mixed strategy of consolidating positions in certain high-tech and financial stocks while divesting from others. The consistent sell-off of UiPath Inc shares and the accumulation of Robinhood Markets Inc stock suggest a strategic shift that market watchers will closely monitor. As always, ARK’s trades provide a window into Cathie Wood’s view of the evolving tech and financial landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.